These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 27347925)

  • 41. Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension.
    Andersen K
    Clin Interv Aging; 2009; 4():137-51. PubMed ID: 19503776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects.
    Schlaich MP; Klingbeil A; Hilgers K; Schobel HP; Schmieder RE
    Am Heart J; 1999 Nov; 138(5 Pt 1):810-7. PubMed ID: 10539810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension.
    Gregori M; Tocci G; Giammarioli B; Befani A; Ciavarella GM; Ferrucci A; Paneni F
    Can J Cardiol; 2014 Feb; 30(2):188-94. PubMed ID: 24461920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelial damage and regeneration: the role of the renin-angiotensin-aldosterone system.
    Becher UM; Endtmann C; Tiyerili V; Nickenig G; Werner N
    Curr Hypertens Rep; 2011 Feb; 13(1):86-92. PubMed ID: 21108024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.
    Turgut F; Balogun RA; Abdel-Rahman EM
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1330-9. PubMed ID: 20498247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current strategies to achieve further cardiac and renal protection through enhanced renin-angiotensin-aldosterone system inhibition.
    Alfie J; Aparicio LS; Waisman GD
    Rev Recent Clin Trials; 2011 May; 6(2):134-46. PubMed ID: 21241234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renin-angiotensin-aldosterone system in normal and hypertensive pregnancy. Response to postural stimuli.
    Fagundes VG; Lamas CC; Francischetti EA
    Hypertension; 1992 Feb; 19(2 Suppl):II74-8. PubMed ID: 1735598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An overview of the classical and tissue-derived renin-angiotensin-aldosterone system and its genetic polymorphisms in essential hypertension.
    Abdel Ghafar MT
    Steroids; 2020 Nov; 163():108701. PubMed ID: 32717198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Actions of circulating angiotensin II and aldosterone in the brain contributing to hypertension.
    Leenen FH
    Am J Hypertens; 2014 Aug; 27(8):1024-32. PubMed ID: 24742639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
    Hirono Y; Yoshimoto T; Suzuki N; Sugiyama T; Sakurada M; Takai S; Kobayashi N; Shichiri M; Hirata Y
    Endocrinology; 2007 Apr; 148(4):1688-96. PubMed ID: 17218415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel RAAS agonists and antagonists: clinical applications and controversies.
    Romero CA; Orias M; Weir MR
    Nat Rev Endocrinol; 2015 Apr; 11(4):242-52. PubMed ID: 25666495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypertension and depressed symptomatology: a cluster related to the activation of the renin-angiotensin-aldosterone system (RAAS). Findings from population based KORA F4 study.
    Häfner S; Baumert J; Emeny RT; Lacruz ME; Bidlingmaier M; Reincke M; Ladwig KH
    Psychoneuroendocrinology; 2013 Oct; 38(10):2065-74. PubMed ID: 23608138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased Susceptibility of Mice Lacking Renin-b to Angiotensin II-Induced Organ Damage.
    Nakagawa P; Nair AR; Agbor LN; Gomez J; Wu J; Zhang SY; Lu KT; Morgan DA; Rahmouni K; Grobe JL; Sigmund CD
    Hypertension; 2020 Aug; 76(2):468-477. PubMed ID: 32507043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylglyoxal, a reactive glucose metabolite, increases renin angiotensin aldosterone and blood pressure in male Sprague-Dawley rats.
    Dhar I; Dhar A; Wu L; Desai KM
    Am J Hypertens; 2014 Mar; 27(3):308-16. PubMed ID: 24436324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical role of direct renin inhibition in hypertension.
    Taylor AA; Pool JL
    Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atrial natriuretic peptide: a new factor in hormonal control of blood pressure and electrolyte homeostasis.
    Atlas SA; Laragh JH
    Annu Rev Med; 1986; 37():397-414. PubMed ID: 2939792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aldosterone inhibits antifibrotic factors in mouse hypertensive heart.
    Azibani F; Benard L; Schlossarek S; Merval R; Tournoux F; Fazal L; Polidano E; Launay JM; Carrier L; Chatziantoniou C; Samuel JL; Delcayre C
    Hypertension; 2012 Jun; 59(6):1179-87. PubMed ID: 22547442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.